TY - JOUR
T1 - YY1 Haploinsufficiency Causes an Intellectual Disability Syndrome Featuring Transcriptional and Chromatin Dysfunction
AU - Gabriele, Michele
AU - Vulto-van Silfhout, Anneke T.
AU - Germain, Pierre Luc
AU - Vitriolo, Alessandro
AU - Kumar, Raman
AU - Douglas, Evelyn
AU - Haan, Eric
AU - Kosaki, Kenjiro
AU - Takenouchi, Toshiki
AU - Rauch, Anita
AU - Steindl, Katharina
AU - Frengen, Eirik
AU - Misceo, Doriana
AU - Pedurupillay, Christeen Ramane J.
AU - Stromme, Petter
AU - Rosenfeld, Jill A.
AU - Shao, Yunru
AU - Craigen, William J.
AU - Schaaf, Christian P.
AU - Rodriguez-Buritica, David
AU - Farach, Laura
AU - Friedman, Jennifer
AU - Thulin, Perla
AU - McLean, Scott D.
AU - Nugent, Kimberly M.
AU - Morton, Jenny
AU - Nicholl, Jillian
AU - Andrieux, Joris
AU - Stray-Pedersen, Asbjørg
AU - Chambon, Pascal
AU - Patrier, Sophie
AU - Lynch, Sally A.
AU - Kjaergaard, Susanne
AU - Tørring, Pernille M.
AU - Brasch-Andersen, Charlotte
AU - Ronan, Anne
AU - van Haeringen, Arie
AU - Anderson, Peter J.
AU - Powis, Zöe
AU - Brunner, Han G.
AU - Pfundt, Rolph
AU - Schuurs-Hoeijmakers, Janneke H.M.
AU - van Bon, Bregje W.M.
AU - Lelieveld, Stefan
AU - Gilissen, Christian
AU - Nillesen, Willy M.
AU - Vissers, Lisenka E.L.M.
AU - Gecz, Jozef
AU - Koolen, David A.
AU - Testa, Giuseppe
AU - de Vries, Bert B.A.
N1 - Funding Information:
We are grateful to the individuals and their parents for their participation. We thank Lone Laulund (Department of Pediatrics, Odense University Hospital) for additional clinical information about deletion case 263711. We thank Giuseppe D'Agostino from the Testa lab for his help in creating the summary figure. This work was supported by the European Commission (GENCODYS grant 241995 under FP7 to A.T.V.-v.S. and B.B.A.d.V.), the European Research Council (grant DISEASEAVATARS 616441 to G.T.), the Telethon Foundation (grants GGP13231B and GGP14265 to G.T.), the Associazione Italiana per la Ricerca sul Cancro (investigator grant to G.T. and fellowship to M.G.), the Regione Lombardia (Ricerca Indipendente 2012 to G.T.), the Umberto Veronesi Foundation (P.-L.G.), the Italian Ministry of Health (ERANET-Neuron grant to P.-L.G. and Ricerca Corrente grant to G.T.), the Japan Agency for Medical Research and Development (research grant to K.K.), the Australian National Health and Medical Research Council (grant 1091593 to J.G.), and the Dutch Organization for Health Research and Development (ZON-MW grants 917-86-319 and 912-12-109 to B.B.A.d.V.).
Publisher Copyright:
© 2017 The Authors
PY - 2017/6/1
Y1 - 2017/6/1
N2 - Yin and yang 1 (YY1) is a well-known zinc-finger transcription factor with crucial roles in normal development and malignancy. YY1 acts both as a repressor and as an activator of gene expression. We have identified 23 individuals with de novo mutations or deletions of YY1 and phenotypic features that define a syndrome of cognitive impairment, behavioral alterations, intrauterine growth restriction, feeding problems, and various congenital malformations. Our combined clinical and molecular data define “YY1 syndrome” as a haploinsufficiency syndrome. Through immunoprecipitation of YY1-bound chromatin from affected individuals’ cells with antibodies recognizing both ends of the protein, we show that YY1 deletions and missense mutations lead to a global loss of YY1 binding with a preferential retention at high-occupancy sites. Finally, we uncover a widespread loss of H3K27 acetylation in particular on the YY1-bound enhancers, underscoring a crucial role for YY1 in enhancer regulation. Collectively, these results define a clinical syndrome caused by haploinsufficiency of YY1 through dysregulation of key transcriptional regulators.
AB - Yin and yang 1 (YY1) is a well-known zinc-finger transcription factor with crucial roles in normal development and malignancy. YY1 acts both as a repressor and as an activator of gene expression. We have identified 23 individuals with de novo mutations or deletions of YY1 and phenotypic features that define a syndrome of cognitive impairment, behavioral alterations, intrauterine growth restriction, feeding problems, and various congenital malformations. Our combined clinical and molecular data define “YY1 syndrome” as a haploinsufficiency syndrome. Through immunoprecipitation of YY1-bound chromatin from affected individuals’ cells with antibodies recognizing both ends of the protein, we show that YY1 deletions and missense mutations lead to a global loss of YY1 binding with a preferential retention at high-occupancy sites. Finally, we uncover a widespread loss of H3K27 acetylation in particular on the YY1-bound enhancers, underscoring a crucial role for YY1 in enhancer regulation. Collectively, these results define a clinical syndrome caused by haploinsufficiency of YY1 through dysregulation of key transcriptional regulators.
KW - H3K27Ac
KW - YY1
KW - chromatin
KW - enhancer
KW - epigenetics
KW - haploinsufficiency
KW - intellectual disability
KW - neurodevelopment
KW - syndrome
KW - transcription factor
UR - http://www.scopus.com/inward/record.url?scp=85020105976&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020105976&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2017.05.006
DO - 10.1016/j.ajhg.2017.05.006
M3 - Article
C2 - 28575647
AN - SCOPUS:85020105976
SN - 0002-9297
VL - 100
SP - 907
EP - 925
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 6
ER -